Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)

Nang Kuang Pharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	263.25	301.54	378.48	401.2	417.12	266.46
Trading Asset Securities	5.05	-	-	1.31	1.28	1.39
Cash & Short-Term Investments	268.29	301.54	378.48	402.51	418.41	267.85
Cash Growth	16.30%	-20.33%	-5.97%	-3.80%	56.21%	-31.93%
Accounts Receivable	405.36	423.08	374.67	386.71	350.44	373.82
Other Receivables	0.29	0.12	1.3	0.15	0.4	1.95
Receivables	405.65	423.2	375.97	386.86	350.84	375.77
Inventory	753.09	709.06	762.62	827.58	701.44	768.39
Prepaid Expenses	37.81	20.36	20.61	23.38	20.71	23.1
Other Current Assets	-	1.83	-	-	-	-
Total Current Assets	1,465	1,456	1,538	1,640	1,491	1,435
Property, Plant & Equipment	2,098	2,105	1,867	1,602	1,682	1,702
Long-Term Investments	109.52	129.12	152.18	118.97	50.29	60.2
Other Intangible Assets	3.6	4.34	5.2	3.87	5.21	3.45
Long-Term Deferred Tax Assets	22	22.02	39.36	27.07	29.84	22.91
Other Long-Term Assets	85.43	95.99	255.08	192.61	169.83	36.72
Total Assets	3,783	3,813	3,856	3,585	3,429	3,260
Accounts Payable	232.6	210.38	166.8	254.3	224.34	188.21
Accrued Expenses	108.15	113.99	100.61	-	-	-
Short-Term Debt	500	450	580	370	479.99	380
Current Portion of Long-Term Debt	8.9	19.86	12.5	12.5	12.5	52
Current Portion of Leases	0.62	0.75	0.49	1.05	1.26	0.45
Current Income Taxes Payable	20.91	11.78	2.7	57.01	46.61	16.77
Current Unearned Revenue	120.33	123.9	127.97	142.49	131.55	121.38
Other Current Liabilities	108.85	212.17	291.63	203.04	176.7	191.22
Total Current Liabilities	1,100	1,143	1,283	1,040	1,073	950.03
Long-Term Debt	188.99	167.26	112.5	25	37.5	50
Long-Term Leases	-	0.37	0.07	0.59	1.55	0.43
Pension & Post-Retirement Benefits	31.2	50.01	53.71	53	53.36	54.64
Long-Term Deferred Tax Liabilities	0.18	0.35	-	1.2	0.26	0.39
Other Long-Term Liabilities	30.1	30.1	30.1	53.33	23.06	0.1
Total Liabilities	1,351	1,391	1,479	1,174	1,189	1,056
Common Stock	1,010	1,010	1,010	1,010	1,010	1,010
Additional Paid-In Capital	245.01	325.8	426.79	457.09	482.34	492.43
Retained Earnings	1,172	1,086	940.46	944.03	748.02	702.24
Comprehensive Income & Other	-0.04	-0.04	-0.03	0.02	-0.04	-0.03
Shareholders' Equity	2,433	2,422	2,377	2,411	2,240	2,205
Total Liabilities & Equity	3,783	3,813	3,856	3,585	3,429	3,260
Total Debt	698.51	638.23	705.56	409.13	532.81	482.88
Net Cash (Debt)	-430.22	-336.69	-327.08	-6.62	-114.4	-215.03
Net Cash Per Share	-4.25	-3.33	-3.23	-0.07	-1.13	-2.12
Filing Date Shares Outstanding	100.99	100.99	100.99	100.99	100.99	100.99
Total Common Shares Outstanding	100.99	100.99	100.99	100.99	100.99	100.99
Working Capital	364.49	313.17	254.99	599.94	418.44	485.09
Book Value Per Share	24.03	23.98	23.54	23.87	22.18	21.83
Tangible Book Value	2,423	2,418	2,372	2,407	2,235	2,201
Tangible Book Value Per Share	23.99	23.94	23.49	23.84	22.13	21.80
Land	767.41	767.41	573.57	247.28	247.28	247.28
Buildings	1,232	1,232	1,134	1,120	1,111	1,105
Machinery	2,641	2,586	2,506	2,431	2,359	2,224
Construction In Progress	126.88	56.54	26.79	36.53	41.57	33.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.